Onychomycosis Market Growth Forecast With Analysis Of Industry Progress Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Onychomycosis Market?

The onychomycosis market has shown robust growth in recent years. It is projected to increase from $3.81 billion in 2025 to $4.03 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. This expansion in the past can be attributed to the significant prevalence of onychomycosis, the constrained availability of advanced antifungal drugs, the rising incidence of fungal nail infections linked to an aging population, enhanced awareness among dermatologists, and the early adoption of topical treatments.

The onychomycosis market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach $5.09 billion, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth is driven by factors such as an escalating need for combination treatments, wider integration of teledermatology and remote patient surveillance, the advancement of AI-powered diagnostic tools, broader distribution channels through hospitals and retail pharmacies, and increased funding for research into resistant fungal strains. Key developments foreseen during this period involve a greater acceptance of individualized antifungal treatments, expanded utilization of teledermatology for both diagnosis and ongoing supervision, the expanding deployment of AI-driven diagnostic instruments for nail infections, heightened public understanding of nail health and proper hygiene, and continuous progress in creating integrated drug and topical treatment options.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12197&type=smp

What Important Drivers Are Powering The Onychomycosis Market Growth?

An increasing number of individuals with diabetes is projected to fuel the expansion of the onychomycosis market in the coming period. Diabetes is a persistent condition resulting from either inadequate insulin production by the pancreas or the body’s inability to effectively use insulin. For individuals living with diabetes, onychomycosis presents a frequent foot ailment, manageable through measures aimed at preventing and addressing its related complications. Consequently, the growing occurrence of diabetes stimulates the demand within the onychomycosis market. As an illustration, in June 2024, data from the National Health Service, a governmental body in the UK, indicated that during 2023, the NHS identified more than half a million (549,000) new individuals in England facing a risk of developing type 2 diabetes. This increased the total count of people with non-diabetic hyperglycemia, also known as pre-diabetes, recorded by a GP, to 3,615,330. This figure marks a notable rise when contrasted with 3,065,825 in 2022, underscoring an approximate 20% increase. Thus, the escalating prevalence of diabetes is a key factor propelling the expansion of the onychomycosis market.

What Key Segment Areas Are Included In The Onychomycosis Market Assessment?

The onychomycosis market covered in this report is segmented –

1) By Type: Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types

2) By Treatment: Drug Treatment, Topical Therapy, Other Treatments

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Distal Subungual Onychomycosis (DSO): Dermatophyte Infections, Mixed Infections

2) By White Superficial Onychomycosis (WSO): Trichophyton Mentagrophytes Infections

3) By Proximal Subungual Onychomycosis (PSO): Associated with Nail Psoriasis, Fungal Infections In Immunocompromised Patients

4) By Candida Onychomycosis: Candidal Nail Infections, Mixed Fungal-Candida Infections

5) By Other Types: Total Nail Dystrophy, Secondary Onychomycosis

Which Trends Are Affecting The Onychomycosis Market Framework?

Leading companies in the online or virtual fitness market are concentrating on developing innovative solutions, such as AI-powered fitness platforms, to address the growing demand for personalized workouts, interactive training, and real-time performance tracking. Artificial intelligence in fitness applications analyzes body movements, offers immediate exercise feedback, and devises customized training plans, providing a more engaging and adaptive experience compared to conventional pre-recorded or static workout programs. For instance, in 2023, vSports by Impakt, a Canada-based company that leads in body tracking and body analysis computer vision software, unveiled a virtual exercise environment complete with AI trainers. Avatars can imitate human actions in virtual settings while also evaluating workouts performed live through a webcam or smartphone using Impakt’s advanced motion-tracking software.

Which Firms Are Competing In The Onychomycosis Market?

Major companies operating in the onychomycosis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr.Reddy’s Laboratories Ltd., Apotex Inc, Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., Zydus Cadila Healthcare Limited.

Access The Complete Onychomycosis Market Report:

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Which Region Holds The Largest Share In The Onychomycosis Market?

North America was the largest region in the onychomycosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Onychomycosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12197&type=smp

Browse Through More Reports Similar to the Global Onychomycosis Market 2026, By The Business Research Company

Interactive Fitness Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/interactive-fitness-global-market-report

Virtual Reality Vr Fitness Game Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-vr-fitness-game-global-market-report

Fitness App Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795